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Maaike G. E. Fenten3, Karin P. W. Schoenmakers3, Petra J. C. Heesterbeek2, Gert Jan Scheffer3 and Rudolf Stienstra1*
Abstract
Background: In what way volume, concentration and dose affect block duration is controversial. The purpose of
the present study is to investigate the effect of dose, volume and concentration of mepivacaine on the duration of
sensory and motor blockade in ultrasound-guided single shot axillary brachial plexus blockade.
Methods: In this parallel group randomized trial conducted in the Sint Maartenskliniek Nijmegen, 45 adult patients
undergoing minor orthopaedic forearm, wrist or hand surgery were randomized to 3 groups. Group A: 20 mL
mepivacaine 1.5 %, Group B: 30 mL mepivacaine 1 % and Group C: 30 mL mepivacaine 1.5 %. Randomization was
computer-generated, with allocation concealment by opaque sequentially numbered sealed envelopes. Patients
and observers were blinded to group allocation. Primary outcome measure: duration of sensory block.
Results: Forty-five patients were randomized, four patients were excluded and replaced, and 15 patients in each
group were included in the analysis. Mean (95 % CI) sensory and motor block duration was 256 (230–282) and 254
(226–282) minutes in Group A, 226 (209–243) and 220 (200–240) minutes in Group B and 270 (249–291) and 264
(244–284) minutes in Group C. Duration of sensory and motor block duration differed significantly between groups
(p = 0.012 and p = 0.016 respectively). Post-hoc analysis showed a significantly reduced sensory and motor block
duration in Group B when compared to Group C of 44 min. No local anesthetic systemic toxicity was reported.
Conclusions: When using mepivacaine for axillary brachial plexus block, a higher dose and concentration was
associated with a longer duration of sensory and motor blockade, but not a higher volume.
Trial Registration: The Netherlands National Trial Register NTR3648. Registered October 3, 2012.
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Background
The introduction of ultrasound has changed the practice
of peripheral nerve block (PNB). Using ultrasound guid-
ance, local anesthetic (LA) spread around the nerves can
be assessed with the possibility of repositioning the nee-
dle in case of maldistribution, [1] allowing for a reduc-
tion in LA dose without compromising the quality of
PNB. Recent publications indeed illustrate that the vol-
ume of LA can be significantly reduced when particular
regional anesthetic techniques are performed with ultra-
sound guidance [2–5]. While dose reduction is advanta-
geous from a safety perspective, an unwanted tradeoff
may be a shorter duration of the nerve blockade.
One of the factors affecting the duration of peripheral
nerve block is the dose of LA, dose being the product of
volume and concentration. In what way volume, concen-
tration and dose of LA affect block duration is subject to
debate [6]. In a recent study, we compared the duration
of sensory and motor block of 15 and 40 mL mepiva-
caine 1.5 % for axillary brachial plexus blockade (ABPB)
using ultrasound guidance [7]. Volume reduction from
40 mL to 15 mL (62.5 %) shortened the overall duration
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of sensory and motor block by approximately 17–19 %,
reduced sensory and motor block duration of individual
nerves by 18–40 % and decreased the time to first request
of postoperative analgesia by approximately 30 %. The dif-
ference in block duration observed in this study was the
effect of either a reduction in volume from 40 to 15 mL or
a reduction in dose from 600 to 225 mg. We designed the
present study to determine if the reduction in duration of
sensory and motor blockade in APBP is mainly affected by
volume reduction or by dose reduction of mepivacaine.
The null hypothesis was that sensory block duration is not
affected by dose and volume reduction.
Methods
This study was set up as a Phase IV, monocenter, double-
blinded (for observer and patient), parallel group random-
ized (1:1:1) trial. No protocol amendments were made
during the study conduct. The study was approved by the
Independent Review Board Nijmegen and was registered
with the Nederlands Trial Register (www.trialregister.nl,
number NTR3648) before onset of participant enrollment.
Eligible patients were all adults aged 18 or over with
ASA physical health classification I–III, scheduled for
single-injection ABPB for hand, wrist or forearm surgery.
Exclusion criteria included contra-indications for regional
anesthesia (infection at the injection site, coagulopathy),
known hypersensitivity to amide-type local anesthetics,
and known history of peripheral neuropathy. Specific cri-
teria for withdrawal and replacement included: failure to
perform adequate single-injection ABPB and failure to
complete the study protocol. Patients were assessed for
eligibility during the preoperative screening visit. Patients
were informed about the study verbally and in writing and
written informed consent was obtained from all patients.
The study was conducted at the Sint Maartenskliniek
Nijmegen, The Netherlands between October 2012 and
June 2014 according to the Declaration of Helsinki
and later revisions thereof and in accordance with the
ICH guidelines for Good Clinical Practice. The Sint
Maartenskliniek specializes in posture and movement.
The orthopedic center is facilitated by an anesthesiology
department specialized in locoregional and regional
anesthesia techniques.
Study procedure
Study medication was prepared by an anesthetic nurse
not involved in the study and was disclosed to the
anesthesiologist performing the block procedure. Study
medication consisted of either 20 mL mepivacaine 1.5 %;
300 mg (Group A), 30 mL mepivacaine 1.0 %; 300 mg
(Group B), or 30 mL mepivacaine 1.5 %; 450 mg (Group C).
After establishing intravenous access and routine mon-
itoring (ECG, non-invasive blood pressure and periph-
eral oxygen saturation), ABPB was performed under
ultrasound guidance using a short axis, in-plane tech-
nique. All blocks were placed by experienced anesthesi-
ologists with the assistance of an anesthetic nurse.
Blocks were performed under aseptic conditions using
chlorhexidine skin preparation and sterile ultrasound
probe covers.
The patient was placed in the supine position with the
head facing away from the arm to be blocked, the arm
abducted and the elbow flexed in 90°. A 100-mm 22-
gauge insulated short bevel needle (Stimuplex®; B. Braun,
Melsungen, Germany) was inserted laterally in the axilla
under ultrasound guidance. The musculocutaneous, me-
dian, ulnar and radial nerve were identified using ultra-
sound and the tip of the needle was brought in proximity
of each individual nerve subsequently. The needle was
connected to a nerve stimulator (Stimuplex® HNS 11; B.
Braun) set to deliver 100 nC (0.1 ms, 1 mA) in order to fa-
cilitate identification of the individual nerves. The nerves
were identified and blocked separately with one fourth of
the study medication per nerve. Per patient one skin
puncture was made, the needle was retracted subcutane-
ously and redirected under ultrasound guidance to ap-
proach the nerves individually. Time was designated t = 0
upon conclusion of the block procedure.
In case of insufficient analgesia at the surgical site at
t = 30 min, an additional rescue block was placed in the
block room, or surgery was performed under general
anesthesia. These patients were excluded from further
analysis and replaced.
Surgery was performed under regional anesthesia. In
case of patient discomfort or upon patient request, sed-
ation was provided with propofol (25–60 μg.kg−1.min−1)
and remifentanil (0.01–0.04 μg.kg−1.min−1).
The patients received paracetamol 1 g orally four
times daily and etoricoxib 90 mg orally once a day, start-
ing on the morning of surgery. When the block started
to wear off, additional postoperative pain treatment con-
sisted of morphine 0.1-0.15 mg/kg every 4 h subcutane-
ously upon patient request.
Primary and secondary outcome measures
The primary outcome parameter was duration of sen-
sory block. Secondary outcome parameters included
duration of motor block, duration of sensory and motor
block of individual nerves, block onset time, time to first
request for additional postoperative pain treatment
(TTFR) and patient satisfaction (NRS 0–10) with the
anesthetic technique.
After injection of the local anesthetic solution, the onset
of sensory and motor block was assessed every 5 min,
until 30 min after injection. Sensory block of the medial
antebrachial cutaneous, musculocutaneous, radial, median
and ulnar nerves was assessed by pinprick. Sensory block
was scored on a three-point scale as 0 = absent, 1 = partial
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and 2 = complete. At the same intervals, motor block of
the musculocutaneous, radial, median and ulnar nerve
was assessed (see Table 1) on a similar three-point scale
(0 = no, 1 = partial and 2 = complete motor block). A
complete overall sensory block was defined as a total score
of 10; complete overall motor block was defined as a total
score of 8.
Upon arrival at the recovery, offset of sensory and motor
block was assessed every 15 min in the same manner as
preoperatively until full recovery. The primary outcome
Table 1 Baseline characteristics
Group A (n = 15) Group B (n = 15) Group C (n = 15)
Sex, no. M/ no. F 2/13 6/9 7/8
Age (yr) 59 ± 9 49 ± 13 53 ± 15
Height (cm) 165 ± 7 172 ± 8 171 ± 11
Weight (kg) 71 ± 13 75 ± 7 78 ± 17
ASA classification, no. 1/no. 2/ no. 3 3/10/2 10/5/0 7/8/0
Duration of surgery (min) 24 ± 17 27 ± 25 34 ± 27
Site of surgery, no. left/ no. right 5/10 5/10 5/10
Type of surgery:
- carpal tunnel release, no. 3 2 4
- trapezoidectomy, no. 6 1 2
- removemal of osteosynthesis material, no. 2 4 1
- arthrodesis of finger, no. 0 2 1
- release trigger finger, no. 2 2 3
- arthrodesis of wrist, no. 0 1 2
- other, no. 2 3 2
Group A: 20 mL mepivacaine 1.5 %. Group B: 30 mL mepivacaine 1.0 %. Group C: 30 mL mepivacaine 1.5 %. Values are absolute numbers, mean ± SD
Fig. 1 Flowchart of patients enrolled in the study
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parameter was overall duration of sensory block defined
as the time from t = 0 until the postoperative measure-
ment where total sensory score had returned to zero.
Overall duration of motor block was defined as the time
from t = 0 until the first postoperative measurement where
total motor score had returned to zero. Block onset time
was defined as the time from t = 0 until the time sensory
respectively motor score was maximal. TTFR was defined
as the time interval from t = 0 until the time the first
request for postoperative analgesia was made.
Sample size, randomization and blinding
The sample size calculation was similar to our previous
study [7] and based on the overall duration of sensory
block. In previous research, we [7], Bugamelli et al. [8],
and Robaux et al. [9] found a variation (SD) in duration
of sensory peripheral nerve block with mepivacaine of ±
47 min (47, 45 and 43 min respectively). Based on these
data, the sample size required to have a 90 % probability
of detecting a difference of 60 min (approximately 25 %)
in duration of the ABPB between the groups (two sided,
Table 2 Block scores of individual nerves at 30 minutes
Group A (n = 15) Group B (n = 15) Group C (n = 15)
Nerve Score 2 Score 1 Score 0 Score 2 Score 1 Score 0 Score 2 Score 1 Score 0
Med. Anteb. Cut. sens 14 1 – 14 1 – 15 – –
Musculocutaneous sens 13 2 – 14 1 – 15 – –
Musculocutaneous mot 13 2 – 12 3 – 14 1 –
Radial sens 14 1 – 10 5 – 14 1 –
Radial mot 14 1 – 12 2 1 13 2 –
Median sens 14 1 – 12 3 – 15 – –
Median mot 13 2 – 14 1 – 15 – –
Ulnar sens 14 1 – 13 1 1 14 1 –
Ulnar mot 14 1 – 14 1 – 15 – –
Group A: 20 mL mepivacaine 1.5 %; Group B: 30 mL mepivacaine 1.0 %; Group C: 30 mL mepivacaine 1.5 %. Med. anteb. cut.: medial antebrachial cutaneous
nerve; sens: sensory block score, mot: motor block score. Block was scored on a three-point scale as 0 = absent, 1 = partial and 2 = complete
Table 3 Duration of axillary plexus nerve block
Group A (n = 15) Group B (n = 15) Group C (n = 15) p-value
Block duration (min)
Overall sensory 256 (230 – 282) 226 (209 – 243) 270 (248 – 291) 0.012
Overall motor 254 (226 – 282) 220 (200 – 240) 264 (244 – 284) 0.016
Block duration (min)
Med. Anteb. Cut. nerve
Sensory 222 (201 – 242) 197 (174–220) 247 (221 – 273) 0.010
Musculocutaneous nerve
Sensory 213 (191 – 235) 196 (175 – 217) 215 (186 – 244) 0.446
Motor 224 (206 – 242) 188 (164 – 212) 216 (197 – 236) 0.031
Radial nerve
Sensory 228 (197 – 259) 207 (190 – 223) 227 (191 – 164) 0.328a
Motor 229 (206 – 251) 209 (190 – 229) 258 (238 – 277) 0.003
Median nerve
Sensory 236 (211 – 261) 204 (185 – 223) 248 (224 – 272) 0.015
Motor 245 (214 – 275) 200 (175 – 225) 241 (222 – 259) 0.015b
Ulnar nerve
Sensory 238 (211 – 265) 211 (189 – 233) 249 (220 – 278) 0.087
Motor 243 (211 – 274) 209 (185 – 234) 257 (236 – 279) 0.025
Group A: 20 mL mepivacaine 1.5 %; Group B: 30 mL mepivacaine 1.0 %; Group C: 30 mL mepivacaïne 1.5 %; med. anteb. cut. nerve: medial antebrachial
cutaneous nerve. ano data because of a postoperative cast or bandage in 6 patients in Group A, 5 patients in Group B and 8 patients in Group C. bno data
because of a postoperative cast or bandage in 3 patients in group A, 2 patients in Group B and 2 patients in Group C. Values are mean (95 % CI)
Bold data represent statistically significant differences
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level of significance 0.05) is 13 patients per group. Com-
pensating for variations in the standard deviation, we
chose to include 15 patients per group. A computer-
generated sequence of random numbers in 3 blocks of
15 and a 1:1:1 allocation was used for randomization.
The allocation sequence was concealed from the re-
searcher assessing and enrolling patients in sequentially
numbered, sealed, opaque envelopes made by an inde-
pendent researcher, not involved in the study.
A computerized database automatically assigned a
study number to each patient assessed for eligibility.
Once included in the study, the study number of the pa-
tient was written on the sealed randomization envelopes
by the researcher. On the day of surgery the envelope
was handed over to an anesthetic nurse not involved in
the study. The anesthetic nurse prepared the study
medication according to the allocated group written on
the card inside the envelope, wrote the study number of
the patient on the card and resealed the envelope.
Patients with specific withdrawal criteria, as men-
tioned earlier in the methods section, were excluded and
replaced. After 45 patients were included in the study,
an independent researcher not involved in the study
made additional sealed envelopes for the patients re-
placing the excluded patients, randomized and sequen-
tially numbered to conceal treatment allocation for the
observer.
At the conclusion of the study, all resealed envelopes
were checked by an independent researcher not involved
in the study, for any violations of the group allocation.
The anesthetic nurse that prepared the study medication
was allowed to disclose allocation to the anesthesiologist
that performed the block procedure. Both patients and
researcher were blinded for the volume and concentration
of anesthetic solution used.
Statistical analysis
Per-protocol analysis was conducted using GraphPad
Prism 6 software (GraphPad Software Inc, San Diego,
CA).
For statistical comparison between the groups of sen-
sory block (primary outcome parameter), motor block
and the duration of individual nerve blocks one-way
ANOVA was used and Tukey post-hoc analyses were
conducted. Block onset time and patient satisfaction
(NRS 0–10) with the anesthetic technique was compared
between groups with the Kruskall Wallis test.
For between group comparison on baseline character-
istics Chi square test and the Kruskall Wallis test were
used. All tests were 2-sided, and a p-value ≤ 0.05 was
considered statistically significant. Frequency distribu-
tion was tested using Kolmogorov-Smirnov test for nor-
mality. Data are presented as mean (95 % confidence
interval) or median [range] as appropriate.
Results
In total, 45 patients were randomized, 15 patients per
group. Four patients were excluded and replaced. Rea-
sons for withdrawal were block failure (three patients in
Group B) and patient consent withdrawal (one patient in
Group A). All patients received the allocated interven-
tion. A CONSORT flowchart is shown in Fig. 1. Baseline
characteristics of the three groups did not differ signifi-
cantly and are described in Table 1.
Thirty minutes after block placement, a complete sen-
sory block was confirmed in 13 patients in Group A, 7 pa-
tients in Group B and 13 patients in Group C (p = 0.006).
Motor block was complete in 13 patients in Group A, 10
patients in Group B and 14 patients in Group C. Data on
sensory and motor block scores of individual nerves after
30 min are shown in Table 2.
Sensory block, as well as motor block duration, differed
significantly between groups: p = 0.012 and p = 0.016, re-
spectively (Table 3). Post-hoc-between-group analyses
showed a statistically shorter sensory and motor block
duration of 44 min (20 %) in Group B when compared
with Group C. Sensory and motor block duration in group
A did not differ significantly from group B and C. Data on
Fig. 2 Duration of overall sensory block (a) and overall motor block
(b) per Group. Group A: 20 mL mepivacaine 1.5 %. Group B: 30 mL
mepivacaine 1.0 %. Group C: 30 mL mepivacaine1.5 %. Dots represent
individual patients, the horizontal lines with error bars represent mean
with SD. *p < 0.05
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between-group differences of sensory and motor block
duration are shown in Fig. 2 and Table 4.
Because of the presence of a postoperative cast, offset
of sensory block of the radial nerve could not be evalu-
ated in 19 patients (6, 5 and 8 patients in Group A, B
and C respectively). In these patients maximum postop-
erative sensory block score was 8 and overall sensory
block duration was defined as the time until the total sen-
sory score had returned to zero. The offset of motor block
of the median nerve could not be tested in 7 patients (3, 2
and 2 patients in Group A, B and C respectively). In these
patients maximum postoperative motor block score was 6
and overall motor block duration was defined as the time
until the total motor score was returned to zero.
Only seven patients requested additional postoperative
pain medication (four in Group A, one in Group B and two
in Group C). Because of the limited number of data on
TTFR, no average TTFR was calculated. Patient satisfaction
with the anesthetic technique (NRS, on a scale 0 – 10) was
comparable between Groups; 8.8 ± 0.8 in Group A, 8.7 ±
1.7 in Group B and 8.9 ± 1.1 in Group C (p = 0.76).
Twenty-eight patients received sedation upon request
during surgery. In all included patients sensory block was
adequate, none of the patients requiring conversion to
general anesthesia. None of the patients showed signs or
symptoms of local anesthetic systemic toxicity during the
study procedure. In our hospital all patients are screened
for postoperative nerve damage three weeks after surgery.
None of the patients enrolled in the study expressed any
sign of nerve damage at the postoperative screening.
Discussion
Because of the inseparable relation between dose, vol-
ume and concentration, the issue which of these three
entities is the major determinant of duration of nervous
blockade is complex. In this study we compared the ef-
fects of equal doses in different volume/concentration,
as well as different dose/concentration in equal volumes,
and different volume/dose in equal concentrations of
mepivacaine for ABPB in order to determine whether
duration of sensory and motor blockade in APBP is
mainly affected by volume, concentration or dose.
Our results show that a higher dose and concentra-
tion administered resulted in a longer duration of sen-
sory and motor block. When comparing the groups
with equal concentrations in our study, no difference
was found in block duration, despite the difference in
dose and volume, suggesting a role for concentration
and not for dose in determining block duration. When
comparing the groups with equal dose, there is a ten-
dency for a longer duration for sensory and motor
block in the group with higher concentration and
Table 4 Groupwise comparisons of block duration
Group A vs Group B Group B vs Group C Group A vs Group C
Difference (95 % CI) p-value Difference (95 % CI) p-value Difference (95 % CI) p-value
Block duration (min)
Overall sensory 30 (−5 – 65) 0.100 −44 (−79 – -9) 0.010 −14 (−49 – 21) 0.599
Overall motor 34 (−3 – 70) 0.079 −44 (−80 – -7) 0.017 −10 (−47 – 27) 0.787
Block duration (min)
Med. Anteb. Cut. nerve
Sensory 24 (−13 – 62) 0.260 -50 (−87 – -12) 0.007 −25 (−63 – 12) 0.244
Musculocutaneous nerve
Sensory 17 (−22 – 56) 0.550 −19 (−58 – 20) 0.482 −2 (−41 – 37) 0.993
Motor 36 (2 – 69) 0.031 −28 (−61 – 5) 0.110 7 (−26 – 41) 0.848
Radial nerve
Sensory 22 (−18 – 61) 0.375 −21 (−63 – 22) 0.451 1 (−43 – 44) 0.999
Motor 20 (−13 – 52) 0.320 −49 (−81 – -16) 0.002 −29 (−62 – 3) 0.086
Median nerve
Sensory 32 (−4 – 69) 0.091 −44 (−80 – -8) 0.014 −12 (−48 – 24) 0.709
Motor 45 (5 – 84) 0.024 −41 (−79 – -2) 0.039 4 (−35 – 44) 0.963
Ulnar nerve
Sensory 27 (−15 – 70) 0.272 −38 (−80 – 4) 0.082 −11 (−53 – 32) 0.818
Motor 34 (−8 – 76) 0.137 −48 (−91 – -6) 0.023 −15 (−57 – 28) 0.684
Group A: 20 mL mepivacaine 1.5 %. Group B: 30 mL mepivacaine 1.0 %. Group C: 30 mL mepivacaine 1.5 %; med. anteb. cut. nerve: medial antebrachial
cutaneous nerve; CI: confidence interval. Values are calculated differences (95 % confidence interval of the difference). Multiplicity adjusted p-values are given
Bold data represent statistically significant differences
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smaller volume. As it is unlikely that a smaller volume
would explain this non-significant trend, this may indi-
cate that concentration is proportional to the duration
of nerve blockade when using equal doses.
Serradell et al. [10] found no differences in the duration
of analgesia when using 36 mL, 28 mL or 20 mL of mepi-
vacaine 1 % for ABPB, suggesting no relation between vol-
ume or dose and duration of analgesia. On the other
hand, several others reported a direct relation between
dose and duration, [7, 11, 12] although in these studies the
higher doses were associated with higher volumes as well.
Therefore it is unclear whether the effect can be attributed
to dose, volume or a combination. In a study using multi-
variate Cox regression to assess the effect of different vol-
umes and concentrations of ropivacaine on the duration
of analgesia following interscalene block for shoulder sur-
gery, Fredrickson et al. [13] concluded that both volume
and concentration affect duration independently.
In a previous study [7] comparing 40 mL and 15 mL
mepivacaine 1.5 % for ABPB, we reported that the vol-
ume/dose reduction of 62.5 % resulted in a shorter
overall duration of sensory and motor block of respect-
ively 17 % and 19 %. In the present study we found that
a dose reduction of 33 % did not result in a reduction
of block duration (Group A versus Group C). Although
comparing results from different studies should be
done with caution, the methodology of our present and
previous study [7] is identical. Combining the observa-
tions from both studies, it seems that the relation between
volume/dose and the duration of nervous blockade is not
linear. Reducing the volume/dose of mepivacaine 1.5 %
from 600 mg (40 mL) to 300 mg (20 mL) results in a mod-
est change in the median duration of nervous blockade of
approximately 5 %; a further decrease to 225 mg (15 mL)
results in a decrease in duration of approximately 18 %
(Fig. 3). It seems therefore that in ABPB with mepivacaine
1.5 %, the optimal balance between volume/dose reduc-
tion without significantly affecting duration of nervous
blockade is 20 mL.
Three patients were excluded from the study because
of block failure, all in Group B. While this may be due
to the lower concentration of mepivacaine, our study
was not set up nor powered to assess success rate of the
different concentrations. In addition, from a clinical per-
spective, 1 % mepivacaine may not be a suitable choice
for ABPB, given the observed failure rate, the inferior
onset characteristics, and the shorter duration.
In the patients randomized to group C we exceeded
the maximum recommended dose of 4.5 mg/kg mepiva-
caine. Maximum recommended doses of local anes-
thetics are usually provided by the manufacturer with
the obvious purpose of minimizing the incidence of sys-
temic toxicity, but that does not mean that these recom-
mendations are tantamount to safety. On the contrary,
maximum recommended doses are controversial because
they are neither evidence based nor specific for site of in-
jection or type of block [14, 15]. In clinical practice larger
doses are frequently used and it is our experience that
450 mg mepivacaine for axillary block in adult patients is
well within the margin of safety.
A limitation of our study is that we were not able to
collect postoperative data of all nerves in all patients be-
cause of the presence of a cast or a compression ban-
dage. However, there were no significant differences in
the duration of sensory and motor block between the
different nerves within each group, with the exception of
motor block duration of the musculocutaneous nerve in
Group C, and we therefore think that the effect of the
missing data on the conclusion of our study is limited.
A second limitation is that our power analysis was based
on a clinically relevant difference of 60 min, whereas in
Fig. 3 Combined data on sensory block duration (a) and motor
block duration (b) of the present study and 13 patients receiving
15 mL and 15 patients receiving 40 mL mepivacaine 1.5 % from
previously published work [7]. Data are presented as mean with
SD. *p < 0.005
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retrospect and from a scientific perspective smaller differ-
ences may also be interesting. The difference in duration
between groups A and B is not statistically significant, but
intriguing nevertheless and possibly a larger sample size
would have unveiled a significant difference. Future re-
search will focus on further investigating the effect of local
anesthetic concentration on duration of sensory and motor
block.
Conclusions
In conclusion, a decrease in volume from 30 to 20 mL
mepivacaine does not influence block duration, but a
higher dose and concentration in equal volumes of
30 mL results in a longer duration of sensory and motor
block in ABPB.
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